آخرون
صورة من داخل مركز طبي للكشف عن الأوبئة الجديدة والفيروسات سريعة العدوى في بريطانيا
آخرون
صورة من داخل مركز طبي للكشف عن الأوبئة الجديدة والفيروسات سريعة العدوى في بريطانيا
The United Kingdom has unveiled a new £1 billion plan to prepare for future pandemics, focusing on enhanced surveillance, stockpiling personal protective equipment (PPE), and establishing a new high-security research center for dangerous pathogens. This investment reflects a growing global concern about emerging infectious diseases and the need for robust public health infrastructure.
The plan, announced by the Department of Health and Social Care on Wednesday, March 26, 2026, acknowledges that another pandemic is “inevitable,” but will differ from previous outbreaks, necessitating flexible and rapid response strategies, according to reports from the British publication, The Telegraph.
A key component of the strategy is the introduction of the All-Hazards Pandemic Preparedness Bill, which will empower the government to activate or modify emergency measures based on the nature and speed of a disease’s spread. The legislation is expected to be finalized by March 2027.
The proposed legislation will adopt a “tiered approach,” allowing for the selection of appropriate measures when a pandemic is declared or imminent, tailored to the specific disease in question.
This new strategy marks a significant shift from the 2011 plan, which focused solely on influenza and faced criticism for leaving the country unprepared during the COVID-19 pandemic.
The plan’s development was informed by Exercise Pegasus, a simulation conducted last year to model the spread of a novel disease and test the government’s response. A full report on the exercise is expected to be published later this year.
Under the plan, the government will invest £1 billion in pandemic preparedness, with the UK Health Security Agency (UKHSA) tasked with creating and operating a new infection-tracking system. This system will utilize real-time location data and artificial intelligence to provide “faster and wider-scale detection and warning during outbreaks.”
The government will also allocate £250 million to construct a high-security science facility in Harlow, Essex, dedicated to studying dangerous pathogens and developing life-saving vaccines, and therapeutics. The center is anticipated to be operational by 2038.
The UK aims to ensure vaccines are available to British citizens within 100 days of a new pandemic outbreak, in collaboration with Moderna, a leading mRNA vaccine manufacturer. Moderna will establish a new facility in Oxfordshire with a production capacity of up to 250 million doses annually.
This move follows criticism of the government’s response to the COVID-19 pandemic in a recent inquiry report, which cited “delayed action” and a failure to adequately prepare for a pandemic that claimed 200,000 lives in the United Kingdom.
The new strategy considers the five primary modes of infectious disease transmission: respiratory, oral, bloodborne, sexual, and contact. It also emphasizes preventing the introduction of pathogens into the UK, drawing on the experiences of countries like South Korea, Taiwan, and Singapore.
“Our new strategy represents a significant improvement in the government’s preparedness for future pandemics, by increasing domestic vaccine production and stockpiling protective equipment for essential workers, to ensure the safety of the community,” said Dan Jarvis, Minister of State for Security.
